Inventor
DEMAREST KEITH T
US17 patents
⚠️ This page may combine multiple inventors who share the name “DEMAREST KEITH T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
8 patentsUS7678786B2Mar 16, 2010
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
JANSSEN PHARMACEUTICA NV8 citations82
US7928238B2Apr 19, 2011
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors
JANSSEN PHARMACEUTICA NV7 citations81
US7351857B2Apr 1, 2008
Methods of using substituted tetralins and indanes
JANSSEN PHARMACEUTICA NV3 citations62
US10195178B2Feb 5, 2019
GPR40 agonists in anti-diabetic drug combinations
JANSSEN PHARMACEUTICA NV1 citations59
US8012963B2Sep 6, 2011
3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US7749995B2Jul 6, 2010
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
JANSSEN PHARMACEUTICA NV0 citations50
US7825110B2Nov 2, 2010
Substituted spiroheterocycles
JANSSEN PHARMACEUTICA NV1 citations49
US7825111B2Nov 2, 2010
Substituted spiroheterocycles
JANSSEN PHARMACEUTICA NV0 citations38
ORTHO MCNEIL PHARM INC
2 patentsUS6653478B2Nov 25, 2003
Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators
ORTHO MCNEIL PHARM INC73 citations89
US6838442B2Jan 4, 2005
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
ORTHO MCNEIL PHARM INC12 citations79